Role of Impaired Central Tolerance to α-Myosin in Inflammatory Heart Disease

Trends in Cardiovascular Medicine

Volumn 22, Issue 5, 2012, Pages 113-117

  Lv, HuiJuan ^a   Lipes, Myra A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MYOSIN HEAVY CHAIN ALPHA;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CHAGAS DISEASE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DRESSLER SYNDROME; HEART DISEASE; HEART MUSCLE INJURY; HISTOCOMPATIBILITY COMPLEX; HUMAN; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIA; ISCHEMIC HEART DISEASE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; STROMA CELL; THYMUS;

ANIMALS; AUTOIMMUNITY; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; CD4-POSITIVE T-LYMPHOCYTES; CENTRAL TOLERANCE; CHAGAS CARDIOMYOPATHY; HEART DISEASES; HUMANS; INFLAMMATION; MYOCARDIAL INFARCTION; MYOCARDITIS; RHEUMATIC HEART DISEASE; RISK ASSESSMENT; RISK FACTORS; THYMUS GLAND; VENTRICULAR MYOSINS;

EID: 84867357020     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.07.005     Document Type: Review

References (40)

1. Andrews R.E., Fenton M.J., Ridout D.A., Burch M. New-onset heart failure due to heart muscle disease in childhood: A prospective study in the United Kingdom and Ireland. Circulation 2008, 117:79-84.
2. Caforio A.L., Grazzini M., Mann J.M., et al. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992, 85:1734-1742.
3. Caforio A.L., Keeling P.J., Zachara E., et al. Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 1994, 344:773-777.
4. Carlquist J.F., Menlove R.L., Murray M.B., et al. HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy: Validation study and meta-analysis of published HLA association studies. Circulation 1991, 83:515-522.
5. Cooper L.T. Myocarditis. N Engl J Med 2009, 360:1526-1538.
6. Cunha-Neto E., Coelho V., Guilherme L., et al. Autoimmunity in Chagas' disease: Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J Clin Invest 1996, 98:1709-1712.
7. Derbinski J., Schulte A., Kyewski B., Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001, 2:1032-1039.
8. k on antigen-presenting cells in the heart. J Exp Med 1995, 182:1291-1300.
9. Dressler W. A post-myocardial infarction syndrome: Preliminary report of a complication resembling idiopathic, recurrent, benign pericarditis. JAMA 1956, 160:1379-1383.
10. Elliott J.F., Liu J., Yuan Z.N., et al. Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAbeta knockout NOD mice. Proc Natl Acad Sci U S A 2003, 100:13447-13452.
11. Eriksson U., Ricci R., Hunziker L., et al. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 2003, 9:1484-1490.
12. Frustaci A., Chimenti C., Calabrese F., et al. Immunosuppressive therapy for active lymphocytic myocarditis: Virological and immunologic profile of responders versus nonresponders. Circulation 2003, 107:857-863.
13. Gallucci S., Lolkema M., Matzinger P. Natural adjuvants: Endogenous activators of dendritic cells. Nat Med 1999, 5:1249-1255.
14. Galvin J.E., Hemric M.E., Kosanke S.D., et al. Induction of myocarditis and valvulitis in Lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis. Am J Pathol 2002, 160:297-306.
15. Giraud M., Taubert R., Vandiedonck C., et al. An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus. Nature 2007, 448:934-937.
16. Gottumukkala R., Lv H., Cornivelli L., et al. Myocardial infarction triggers chronic cardiac autoimmunity in type 1 diabetes. Sci Transl Med 2012, 4:138ra80.
17. Gregersen P.K., Olsson L.M. Recent advances in the genetics of autoimmune disease. Annu Rev Immunol 2009, 27:363-391.
18. Kohno K., Takagaki Y., Aoyama N., et al. A peptide fragment of beta cardiac myosin heavy chain (beta-CMHC) can provoke autoimmune myocarditis as well as the corresponding alpha cardiac myosin heavy chain (alpha-CMHC) fragment. Autoimmunity 2001, 34:177-185.
19. Kyewski B., Klein L. A central role for central tolerance. Annu Rev Immunol 2006, 24:571-606.
20. Lappé J.M., Pelfrey C.M., Tang W.H. Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy. J Card Fail 2008, 14:521-530.
21. Lv H., Havari E., Pinto S., et al. Impaired thymic tolerance to alpha-myosin directs autoimmunity to the heart in mice and humans. J Clin Invest 2011, 121:1561-1573.
22. Marin-Neto J.A., Cunha-Neto E., Maciel B.C., Simões M.V. Pathogenesis of chronic Chagas heart disease. Circulation 2007, 115:1109-1123.
23. McKenna C.J., Codd M.B., McCann H.A., Sugrue D.D. Idiopathic dilated cardiomyopathy: Familial prevalence and HLA distribution. Heart 1997, 77:549-552.
24. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
25. Miyata S., Minobe W., Bristow M.R., Leinwand L.A. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res 2000, 86:386-390.
26. Moraru M., Roth A., Keren G., George J. Cellular autoimmunity to cardiac myosin in patients with a recent myocardial infarction. Int J Cardiol 2006, 107:61-66.
27. Mueller D.L. Mechanisms maintaining peripheral tolerance. Nat Immunol 2010, 11:21-27.
28. Neu N., Beisel K.W., Traystman M.D., et al. Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis. J Immunol 1987, 138:2488-2492.
29. Neu N., Rose N.R., Beisel K.W., et al. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987, 139:3630-3636.
30. Pontes-de-Carvalho L., Santana C.C., Soares M.B., et al. Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens. J Autoimmun 2002, 18:131-138.
31. Pugliese A., Zeller M., Fernandez A., et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997, 15:293-297.
32. Pummerer C.L., Luze K., Grässl G., et al. Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. J Clin Invest 1996, 97:2057-2062.
33. + T cells against myosin in mice chronically infected with Trypanosoma cruzi. Infect Immun 1989, 57:2640-2644.
34. Smith S.C., Allen P.M. Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol 1991, 147:2141-2147.
35. Stewart G.C., Lopez-Molina J., Gottumukkala R.V., et al. Myocardial parvovirus B19 persistence: Lack of association with clinicopathologic phenotype in adults with heart failure. Circ Heart Fail 2011, 4:71-78.
36. Taylor J.A., Havari E., McInerney M.F., et al. A spontaneous model for autoimmune myocarditis using the human MHC molecule HLA-DQ8. J Immunol 2004, 172:2651-2658.
37. Tydén G., Reinholt F.P., Sundkvist G., Bolinder J. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 1996, 335:860-864.
38. Vafiadis P., Bennett S.T., Todd J.A., et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997, 15:289-292.
39. von Boehmer H., Melchers F. Checkpoints in lymphocyte development and autoimmune disease. Nat Immunol 2010, 11:14-20.
40. Wolfgram L.J., Beisel K.W., Rose N.R. Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis. J Exp Med 1985, 161:1112-1121.